Vertex Pharmaceuticals Incorporated (VX1.F)
Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
At close: 03:31PM CEST
| Previous close | 387.50 |
| Open | 388.50 |
| Bid | 392.35 x 10000 |
| Ask | 392.80 x 10000 |
| Day's range | 388.50 - 390.15 |
| 52-week range | 299.75 - 420.95 |
| Volume | |
| Avg. volume | 54 |
| Market cap | 101.205B |
| Beta (5Y monthly) | 0.39 |
| PE ratio (TTM) | 27.18 |
| EPS (TTM) | 14.30 |
| Earnings date | 30 Jul 2024 - 05 Aug 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 258.59 |
GuruFocus.comAlpine Immune Sciences Inc (ALPN) Reports Q1 2024 Financials Amid Pending Acquisition by Vertex ...
Financial Performance Aligns with Analyst Projections Despite Revenue Dip
ZacksCRISPR's (CRSP) Q1 Loss Narrower-Than-Expected, Sales Miss
CRISPR Therapeutics (CRSP) reports mixed earnings results for first-quarter 2024. Management claims that the commercial launch for the first ever CRISPR-based gene therapy is progressing well.
Simply Wall St.Results: Vertex Pharmaceuticals Incorporated Exceeded Expectations And The Consensus Has Updated Its Estimates
As you might know, Vertex Pharmaceuticals Incorporated ( NASDAQ:VRTX ) just kicked off its latest quarterly results...
© 2024 Yahoo. All rights reserved.